Fresenius SE & Co KGaA
MIL:FRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
V
|
Vinci SA
SWB:SQU
|
FR |
|
D
|
Deutsche Post AG
F:DPW
|
DE |
|
NVIDIA Corp
SIX:NVDA
|
US |
|
W
|
Wells Fargo & Co
F:NWT
|
US |
|
M
|
Minth Group Ltd
OTC:MNTHY
|
TW |
|
N
|
Nucor Corp
XMUN:NUO
|
US |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
Intrinsic Value
Is FRE undervalued or overvalued?
See the intrinsic value estimate for 
Fresenius SE & Co KGaA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Fresenius SE & Co KGaA Does
Fresenius SE & Co KGaA is a healthcare company that makes medical products and runs hospitals. Its product side, Fresenius Kabi, sells things like IV fluids, injectable medicines, clinical nutrition products, infusion pumps, and other supplies used in hospitals and clinics. Its hospital side treats patients through large hospital networks in Germany and Spain, where it provides inpatient care, surgeries, and related medical services.
- Headquarters
- Germany DE
- Employees
- 316 078
- IPO date
- Dec 18, 1986
Fresenius SE & Co KGaA has no economic moat
Competing suppliers offer alternatives to many Fresenius medicines and hospital products, while other hospital operators compete for its patients. Its size and reputation help it compete, but do not give it lasting control over customers or prices.
Read the full moat analysis
Revenue & Expenses Breakdown
Fresenius SE & Co KGaA
Earnings Waterfall
Fresenius SE & Co KGaA
The intrinsic value for Fresenius SE & Co KGaA (FRE) under the Base Case is hidden EUR.
Compared with the current market price of 0.17 EUR, the stock appears hidden.
